Member Exclusive News

Novel drug candidate could treat visceral leishmaniasis

Collaborative research between the University of Dundee, GSK and Wellcome has uncovered a new preclinical drug candidate that could treat one of the world’s major neglected diseases.

Go to the profile of Jasmine Harris
Jul 27, 2018

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.